Designing highly multiplex PCR primer sets with Simulated Annealing Design using Dimer Likelihood Estimation (SADDLE)
Nina Guanyi Xie(Shanghai Medical Information Center), David Y. Zhang(VA NY Harbor Healthcare System), Junfeng Luo, Shiqi Mao(Tongji University), Yifan Wang(Gansu Agricultural University), Ping Song(The University of Texas MD Anderson Cancer Center), Michael Wang, Yuxia Yang(Institute of Agro-Products Processing Science and Technology), Shengxiang Ren(Tongji University)
Cited by 95
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
|Annals of Oncology|2015|467
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Transcriptional landscape of rice roots at the single-cell resolution
|Molecular Plant|2020|255